publication date: Mar. 15, 2019

Trump proposal for FY2020 to slash NIH by 12 percent, NCI by 15 percent

By Claire Dietz and Matthew Bin Han Ong

President Donald Trump has proposed to cut $4.7 billion from the NIH budget, with almost $900 million coming out of NCI during the fiscal year 2020.

According to the White House’s proposal, “A Budget for a Better America: Promises Kept. Taxpayers First.” released March 11, NIH would lose 12 percent and NCI, 15 percent.

If Trump’s budget request is enacted, the NIH budget would shrink from $39.1 billion in FY19 to $34.4 billion in FY20. The NCI budget would be slashed to $5.2 billion, down from $6.1 billion.

Trump’s latest budget proposal marks the third consecutive year in which he has advocated for severe cuts to federal agencies that fund biomedical research (The Cancer Letter, May 26, 2017, Feb. 16, 2018). These cuts are proposed without explanation or justification.

FDA, by contrast, stands to get a $643 million boost above the FY19 continuing resolution level, which would bring the agency’s budget to $6.1 billion. The budget proposal would also increase user fees by $281 million, and the FDA budget authority by $362 million.

The Health Resources and Services Administration would get a $1 billion cut, and the Centers for Disease Control and Prevention would lose $1.3 billion. The budget also reduces funding for cancer screening and prevention programs  by $34.5 million at CDC.

Trump’s FY20 budget focuses on boosting funding for the Department of Defense by $33.4 billion—a 5 percent increase. Of that amount, $3.6 billion would be allocated to “new military construction resources for barriers,” bringing total funding proposal … Continue reading Trump proposal for FY2020 to slash NIH by 12 percent, NCI by 15 percent

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.